Skip to content

A multi-center randomized controlled trial of Liu Jiaxiang Qi-Yin Recipe for improving the prognosis of patients with stage IIIA non-small cell lung cancer after radical resection

A multi-center randomized controlled trial of Liu Jiaxiang Qi-Yin Recipe for improving the prognosis of patients with stage IIIA non-small cell lung cancer after radical resection

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000002957
Enrollment
Unknown
Registered
2020-02-02
Start date
2020-02-07
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Control group:Conventional treatment

Sponsors

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In stage IIIA patients undergoing radical surgery, postoperative pathology confirmed NSCLC; 2. Within 1 month after completion of 4 cycles of adjuvant chemotherapy (IIIA-N2 patients can receive adjuvant radiotherapy), no recurrence or metastasis occurred; 3. During the postoperative adjuvant (radiation) treatment, no Chinese medicine was received; 4. TCM syndrome differentiation is Qi deficiency, Yin deficiency or Qi deficiency; 5. Aged between 18 and 75 years old; 6. Physical performance score (ECOG PS) <=3 points. 7. Blood routine, liver and kidney function were normal. 8. Patients have good compliance, can understand the situation of this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. The expected survival time is less than 6 months; 2. No clear pathological diagnosis; 3. The patient had severe diseases such as heart, liver, kidney and hematopoietic system; 4. pregnant or lactating patients; 5. People with a history of mental illness that is difficult to control.

Design outcomes

Primary

MeasureTime frame
Disease-free survival, DFS;

Secondary

MeasureTime frame
symptoms lists questionnaire otraditional Chinese medicine;Quality of life;2-year disease-free survival rate;Overall survival;

Countries

China

Contacts

Public ContactLingshuang Liu
liuls107@163.com+86 13818510253

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026